The Oregon Board of Pharmacy adopted the Interpretive Labeling rules implementing Senate Bill 698, noting the Board’s ability to use its discretion in enforcement and asking Board staff to prepare clarification to the rules with regard to the use of informational inserts for lengthy prescription instructions. NACDS is requesting specific clarification from the Board and will provide updates as they become available.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.